LE WE PMID CA
Depression649Depression

Agomelatine

Anhedonia

Antidepressive agents

Brain injury

Circadian clock

CNS (Cortex stimulation)

CNS (Deep brain stimulation)

CNS (Glia)

CNS (Limbic system)

CNS (Magnetic stimulation)

CNS (MRS)

CNS (Vagus stimulation)

Cognitive behavior therapy

COPD

Depression

Desvenlafaxine

Duloxetine

Emotion (Neurophysiology)

Endocannabinoid

Endophenotype

Escitalopram

Imaging (Molecular)

L Methylfolate

Lamotrigine

Leptin

Lithium

Mirtazapine

Myalgic encephalomyelitis AKA Fibromyalgia

Neuroimmunology

Nucleus accumbens

Pain (Neurophysiology)

Phobia (Neurophysiology)

Post traumatic stress disorder

Prefrontal cortex

Psychodysleptic agents

Psychosurgery

Quetiapine

Reboxetine

Reward (Neurophysiology)

Social rejection

Stress (Neurophysiology)

2008  
1
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.
[18832497] Psychiatr Serv 59(10): 1121-30 (2008)
2000  
2
A review of pharmacotherapy of major depression in children and adolescents.
[10783181] Psychiatr Serv 51(5): 627-33 (2000)
1999  
3
A systematic review of the mortality of depression.
[10024062] Psychosom Med 61(1): 6-17 (1999)
1999  
4
Status of treatment of depression.
[10498158] South Med J 92(9): 846-56 (1999)
1996  
5
The neuroendocrinology of depression and chronic stress.
[8949260] Br Med Bull 52(3): 597-617 (1996)
2003  
6
Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians.
[12729245] Can Fam Physician 49(-): 489-91 (2003)
1994  
7
Adolescent depression. Part 2. Treatment.
[7920052] Can Fam Physician 40(-): 1591-4, 1597-8 (1994)
1994  
8
Adolescent depression. Part 1. Diagnosis.
[7920051] Can Fam Physician 40(-): 1583-7 (1994)
2008  
9
Treatment of depressive disorders.
[19578410] Dtsch Arztebl Int 105(45): 782-92 (2008)
2008  
10
Depression in children and adolescents.
[19633781] Dtsch Arztebl Int 105(9): 149-55 (2008)
2007  
11
The homocysteine hypothesis of depression.
[17541043] Am J Psychiatry 164(6): 861-7 (2007)
2009  
12
The prevention of depression in children and adolescents: a review.
[19321027] Can J Psychiatry 54(4): 212-21 (2009)
2007  
13
Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
[17953159] Can J Psychiatry 52(9): 553-62 (2007)
2007  
14
Long-term treatment of depression with antidepressants: a systematic narrative review.
[17953158] Can J Psychiatry 52(9): 545-52 (2007)
2003  
15
Major depressive disorder in adolescence: a brief review of the recent treatment literature.
[14631880] Can J Psychiatry 48(9): 600-6 (2003)
2003  
16
Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
[12971013] Can J Psychiatry 48(7): 440-8 (2003)
2001  
17
Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden.
[11441768] Can J Psychiatry 46 Suppl 1(-): 13S-20S (2001)
2001  
18
Clinical guidelines for the treatment of depressive disorders. II. Principles of management.
[11441769] Can J Psychiatry 46 Suppl 1(-): 21S-28S (2001)
2001  
19
Clinical guidelines for the treatment of depressive disorders. III. Psychotherapy.
[11441770] Can J Psychiatry 46 Suppl 1(-): 29S-37S (2001)
2001  
20
Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.
[11441771] Can J Psychiatry 46 Suppl 1(-): 38S-58S (2001)
2001  
21
Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy.
[11441772] Can J Psychiatry 46 Suppl 1(-): 59S-62S (2001)
2001  
22
Clinical guidelines for the treatment of depressive disorders. VI. Special populations.
[11441773] Can J Psychiatry 46 Suppl 1(-): 63S-76S (2001)
2001  
23
Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity.
[11441774] Can J Psychiatry 46 Suppl 1(-): 77S-90S (2001)
2009  
24
Systematic review of lithium augmentation in depression resistant to at least 2 antidepressants.
[19750072] Prim Care Companion J Clin Psychiatry 11(4): 172 (2009)
2007  
25
Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.
[17998951] Prim Care Companion J Clin Psychiatry 9(5): 331-7 (2007)
2006  
26
2009  
27
Persisting decline in depression treatment after FDA warnings.
[19487628] Arch Gen Psychiatry 66(6): 633-9 (2009)
2006  
28
Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.
[17088502] Arch Gen Psychiatry 63(11): 1217-23 (2006)
2004  
29
Combined pharmacotherapy and psychological treatment for depression: a systematic review.
[15237083] Arch Gen Psychiatry 61(7): 714-9 (2004)
1999  
30
Algorithms for the pharmacotherapy of major depression.
[10560904] Psychiatry Clin Neurosci 53 Suppl(-): S77-82 (1999)
2008  
31
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.
[18504424] Mol Psychiatry 13(11): 993-1000 (2008)
2007  
32
A review of quetiapine in combination with antidepressant therapy in patients with depression.
[19300621] Neuropsychiatr Dis Treat 3(6): 855-67 (2007)
2005  
33
Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients.
[18568129] Neuropsychiatr Dis Treat 1(1): 59-68 (2005)
2002  
34
Neurobiology of depression.
[11931738] Neuron 34(1): 13-25 (2002)
2000  
35
Major depressive disorder.
[11144343] Neuron 28(2): 335-41 (2000)
2008  
36
Treatment strategies to improve and sustain remission in major depressive disorder.
[19170395] Dialogues Clin Neurosci 10(4): 377-84 (2008)
2008  
37
Towards achieving remission in the treatment of depression.
[19170394] Dialogues Clin Neurosci 10(4): 371-5 (2008)
2008  
38
Diurnal variation of depressive symptoms.
[18979947] Dialogues Clin Neurosci 10(3): 337-43 (2008)
2008  
39
Towards a scientific taxonomy of depression.
[18979943] Dialogues Clin Neurosci 10(3): 301-8 (2008)
2008  
40
2008  
41
Core symptoms of major depressive disorder: relevance to diagnosis and treatment.
[18979940] Dialogues Clin Neurosci 10(3): 271-7 (2008)
2008  
42
2006  
43
Experimental animal models for the simulation of depression and anxiety.
[17117614] Dialogues Clin Neurosci 8(3): 323-33 (2006)
2006  
44
Depression and associated physical diseases and symptoms.
[16889110] Dialogues Clin Neurosci 8(2): 259-65 (2006)
2006  
45
Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.
[16889109] Dialogues Clin Neurosci 8(2): 241-58 (2006)
2006  
46
2006  
47
Depression and sleep: pathophysiology and treatment.
[16889107] Dialogues Clin Neurosci 8(2): 217-26 (2006)
2006  
48
2006  
49
Future prospects in depression research.
[16889104] Dialogues Clin Neurosci 8(2): 175-89 (2006)
2006  
50
2005  
51
Neuroendocrine predictors of the evolution of depression.
[16156385] Dialogues Clin Neurosci 7(3): 273-82 (2005)
2005  
52
The pharmacological management of depression.
[16156378] Dialogues Clin Neurosci 7(3): 191-205 (2005)
2009  
53
The role of L-methylfolate in depressive disorders.
[19169195] CNS Spectr 14(1 Suppl 2): 2-7 (2009)
2008  
54
Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.
[19179943] CNS Spectr 13(12): 1066-86; quiz 1087-8 (2008)
2008  
55
The future of depression psychopharmacology.
[18704023] CNS Spectr 13(8): 682-7 (2008)
2008  
56
Inflammation, glutamate, and glia in depression: a literature review.
[18567974] CNS Spectr 13(6): 501-10 (2008)
2007  
57
Augmentation strategies in the treatment of major depressive disorder. Examining the evidence on augmentation with atypical antipsychotics.
[18396509] CNS Spectr 12(12 Suppl 22): 10-2 (2007)
2007  
58
Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies.
[18396508] CNS Spectr 12(12 Suppl 22): 6-9 (2007)
2007  
59
Augmentation strategies for depression: history and concepts.
[18396507] CNS Spectr 12(12 Suppl 22): 3-5 (2007)
2007  
60
Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent.
[17934378] CNS Spectr 12(10): 739-44 (2007)
2007  
61
Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
[17986951] CNS Spectr 12(8 Suppl 13): 1-27 (2007)
2006  
62
Clinical assessment of suicide risk in depressive disorder.
[16816777] CNS Spectr 11(6): 455-61 (2006)
2005  
63
Lamotrigine augmentation strategy for patients with treatment-resistant depression.
[16400242] CNS Spectr 10(10): 800-5 (2005)
2004  
64
Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.
[15520605] CNS Spectr 9(11): 808-16, 818-21 (2004)
2010  
65
Agomelatine: The evidence for its place in the treatment of depression.
[20694073] Core Evid 4(-): 171-9 (2010)
2010  
66
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.
[20694066] Core Evid 4(-): 67-82 (2010)
2008  
67
The molecular neurobiology of depression.
[18923511] Nature 455(7215): 894-902 (2008)
2008  
68
Potential surgical targets for deep brain stimulation in treatment-resistant depression.
[18590380] Neurosurg Focus 25(1): E3 (2008)
2008  
69
Biological basis for the surgical treatment of depression.
[18590379] Neurosurg Focus 25(1): E2 (2008)
2007  
70
2005  
71
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
[16172440] Ann Intern Med 143(6): 415-26 (2005)
2009  
72
Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder.
[19721844] J Psychiatry Neurosci 34(5): 343-9 (2009)
2004  
73
Implications of adult hippocampal neurogenesis in antidepressant action.
[15173896] J Psychiatry Neurosci 29(3): 196-205 (2004)
2004  
74
Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.
[15173895] J Psychiatry Neurosci 29(3): 185-93 (2004)
2001  
75
Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.
[11590967] J Psychiatry Neurosci 26 Suppl(-): S3-10 (2001)
1997  
76
Refractory depression: treatment strategies, with particular reference to the thyroid axis.
[9401313] J Psychiatry Neurosci 22(5): 327-31 (1997)
1993  
77
Can drugs cause depression? A review of the evidence.
[8499431] J Psychiatry Neurosci 18(3): 92-102 (1993)
1993  
78
Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.
[8461280] J Psychiatry Neurosci 18(1): 4-16 (1993)
2010  
79
Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.
[20101419] Acta Neurochir (Wien) 152(4): 565-77 (2010)
2010  
80
Treatment of depressed adolescents.
[20595423] Am J Psychiatry 167(7): 734-7 (2010)
2007  
81
What have we learned about the neurobiology of major depression?
[17403962] Am J Psychiatry 164(4): 540-2 (2007)
2005  
82
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence.
[15800134] Am J Psychiatry 162(4): 656-62 (2005)
2008  
83
2010  
84
Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
[20940209] BMJ 341(-): c4737 (2010)
2008  
85
Management of depression in adults.
[18292169] BMJ 336(7641): 435-9 (2008)
2010  
86
Use of deep brain stimulation in treatment-resistant depression.
[20622083] Cleve Clin J Med 77 Suppl 3(-): S77-80 (2010)
2010  
87
Accuracy of depression screening tools for identifying postpartum depression among urban mothers.
[20156899] Pediatrics 125(3): e609-17 (2010)
2010  
88
A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.
[20431115] Mayo Clin Proc 85(6): 538-50 (2010)
2011  
89
Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.
[22021869] BMJ Open 1(2): e000106 (2011)
2010  
90
New therapeutic targets for mood disorders.
[20419280] ScientificWorldJournal 10(-): 713-26 (2010)
2002  
91
A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety.
[12433315] Health Technol Assess 6(22): 1-89 (2002)
2009  
92
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.
[19589048] Expert Rev Neurother 9(7): 975-84 (2009)
2009  
93
2009  
94
Neurobiology of depression, fibromyalgia and neuropathic pain.
[19482616] Front Biosci 14(-): 5291-338 (2009)
2008  
95
Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia.
[17465696] Physiol Res 57(2): 151-64 (2008)
2009  
96
First-line pharmacotherapies for depression - what is the best choice?
[19776688] Pol Arch Med Wewn 119(7-8): 478-86 (2009)
2007  
97
The leptin hypothesis of depression: a potential link between mood disorders and obesity?
[18032111] Curr Opin Pharmacol 7(6): 648-52 (2007)
2009  
98
Stress-induced dendritic remodeling in the medial prefrontal cortex: effects of circuit, hormones and rest.
[19361488] Brain Res 1293(-): 108-13 (2009)
2010  
99
Continuation treatment of major depressive disorder: is there a case for duloxetine?
[20368904] Drug Des Devel Ther 4(-): 19-31 (2010)
2008  
100
Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms.
[18784657] Nat Rev Neurosci 9(10): 788-96 (2008)
2011  
101
Comparative efficacy of escitalopram in the treatment of major depressive disorder.
[21430793] Neuropsychiatr Dis Treat 7(-): 39-49 (2011)
2007  
102
A review of etiologies of depression in COPD.
[18268923] Int J Chron Obstruct Pulmon Dis 2(4): 485-91 (2007)
2009  
103
Treatment for depression after traumatic brain injury: a systematic review.
[19698070] J Neurotrauma 26(12): 2383-402 (2009)
2010  
104
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.
[21358978] Curr Neuropharmacol 8(3): 287-304 (2010)
2006  
105
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents.
[18654637] Curr Neuropharmacol 4(4): 277-91 (2006)
2002  
106
Transcranial magnetic stimulation: a new tool in the fight against depression.
[22033886] Dialogues Clin Neurosci 4(1): 93-103 (2002)
2011  
107
Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression.
[21485753] Dialogues Clin Neurosci 13(1): 139-45 (2011)
2011  
108
Depressogenic effects of medications: a review.
[21485751] Dialogues Clin Neurosci 13(1): 109-25 (2011)
2011  
109
2004  
110
Discovering endophenotypes for major depression.
[15213704] Neuropsychopharmacology 29(10): 1765-81 (2004)
2010  
111
2006  
112
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.
[16641939] Neuropsychopharmacology 31(7): 1345-55 (2006)
2010  
113
Black sheep get the blues: a psychobiological model of social rejection and depression.
[20083138] Neurosci Biobehav Rev 35(1): 39-45 (2010)
2010  
114
A critical review of human endotoxin administration as an experimental paradigm of depression.
[19666048] Neurosci Biobehav Rev 34(1): 130-43 (2010)
2007  
115
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
[17945507] Pharmacol Res 56(5): 360-6 (2007)
2010  
116
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.
[20151847] Expert Opin Pharmacother 11(5): 709-22 (2010)
2010  
117
Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.
[20406250] CNS Neurosci Ther 16(3): e1-17 (2010)
2010  
118
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
[20453533] Neuropsychobiology 62(1): 36-42 (2010)
2007  
119
Serotonin-1A receptor imaging in recurrent depression: replication and literature review.
[17921037] Nucl Med Biol 34(7): 865-77 (2007)
2011  
120
In search of HPA axis dysregulation in child and adolescent depression.
[21290178] Clin Child Fam Psychol Rev 14(2): 135-60 (2011)
2011  
121
Disruption of circadian rhythms: a crucial factor in the etiology of depression.
[21845223] Depress Res Treat 2011(-): 839743 (2011)
2011  
122
Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder.
[21197097] Depress Res Treat 2011(-): 650450 (2011)
2010  
123
Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.
[20147575] J Psychopharmacol 24(8): 1143-52 (2010)
2010  
124
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.
[19944762] Neurobiol Dis 37(3): 519-33 (2010)
2010  
125
The genetics of major depression: moving beyond the monoamine hypothesis.
[20159343] Psychiatr Clin North Am 33(1): 125-40 (2010)
2007  
126
The molecular neurobiology of depression.
[17362799] Psychiatr Clin North Am 30(1): 1-11 (2007)
2007  
127
How to increase serotonin in the human brain without drugs.
[18043762] J Psychiatry Neurosci 32(6): 394-9 (2007)
2010  
128
From synapse to nucleus: novel targets for treating depression.
[20018197] Neuropharmacology 58(4-5): 683-93 (2010)
2005  
129
Beyond monoamines: glutamatergic function in mood disorders.
[16400244] CNS Spectr 10(10): 808-19 (2005)
2010  
130
Depression research: where are we now?
[20219105] Mol Brain 3(-): 8 (2010)
2010  
131
Interoception in anxiety and depression.
[20490545] Brain Struct Funct 214(5-6): 451-63 (2010)
2007  
132
Gliogenesis and glial pathology in depression.
[17511618] CNS Neurol Disord Drug Targets 6(3): 219-33 (2007)
2009  
133
The bright side of being blue: depression as an adaptation for analyzing complex problems.
[19618990] Psychol Rev 116(3): 620-54 (2009)
2009  
134
The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex.
[19428640] Behav Brain Res 201(2): 239-43 (2009)
2011  
135
Meta-review of the effectiveness of computerised CBT in treating depression.
[21838902] BMC Psychiatry 11(-): 131 (2011)
2007  
136
Social neuroscience of child and adolescent depression.
[17624647] Brain Cogn 65(1): 47-68 (2007)
2011  
137
SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
[21286371] J Can Acad Child Adolesc Psychiatry 20(1): 60-7 (2011)
2010  
138
Pharmaceutical treatment of acute bipolar depression.
[20948837] F1000 Med Rep 2(-): - (2010)
2011  
139
Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala.
[21111403] Biol Psychiatry 69(12): e43-54 (2011)
2010  
140
Deep brain stimulation for treatment-resistant depression.
[21131410] Am J Psychiatry 167(12): 1437-44 (2010)
2010  
141
The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression.
[20418774] J ECT 26(4): 323-9 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Depressive Störungen bei Kindern und Jugendlichen, Behandlung von


  • Search PubMed and many other databases on the combined search terms

    GG: depression
    GG: depressive disorder
    GG: depressive episode

  • Depression

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia